![Tillotts Pharma AG announces launch of ASACOLTM 1600 mg (mesalazine)* for ulcerative colitis | Tillotts Global Tillotts Pharma AG announces launch of ASACOLTM 1600 mg (mesalazine)* for ulcerative colitis | Tillotts Global](https://www.tillotts.com/wp-content/uploads/2019/01/asacol-1600_30-60_boxes_blisters_tablets-800x533.jpg)
Tillotts Pharma AG announces launch of ASACOLTM 1600 mg (mesalazine)* for ulcerative colitis | Tillotts Global
![Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy](https://c8.alamy.com/comp/WPHK7W/octasa-400-mg-modified-release-tablets-active-substance-mesalazine-used-to-treat-mild-to-moderate-attacks-of-ulcerative-colitis-WPHK7W.jpg)
Octasa 400 mg Modified Release Tablets (Active substance: mesalazine) used to treat mild to moderate attacks of ulcerative colitis Stock Photo - Alamy
![Laura @Me & Mr Jones on Twitter: "Doc gave me something new to try - what's your experience with it? #Crohns #ibd #mesalazine https://t.co/p0gcAG9ADm" / Twitter Laura @Me & Mr Jones on Twitter: "Doc gave me something new to try - what's your experience with it? #Crohns #ibd #mesalazine https://t.co/p0gcAG9ADm" / Twitter](https://pbs.twimg.com/media/CsU_V5fWIAAhsoM.jpg:large)